“There’s a 15 Minute Window on a Certain Tuesday” | Why Your Biotech Can’t Get Funded | Stone & Wiklund
Two cell and gene therapy CEOs who actually closed funding explain why there’s a 15-minute window on a certain Tuesday to fit investor criteria, why investors move in herds toward in vivo CAR-T while vaccines are unfundable, and why China now leads in advanced therapy clinical trials.